Figure 3
Functional studies of the role of miR-451 in erythroid maturation. (A) miR-451 deficiency, but not miR-144 deficiency, is sufficient to cause erythroid immaturity. MO miRNA antagonists or control MO was microinjected, tracing delivery by rhodamine (schematic diagram) and the N:C area ratio computed as an indicator of maturation (table). O-diansidine staining confirmed normal hemoglobinization in MO-injected embryos at 48 hpf (compare Figure 2C); embryos in panels are representative of at least 16 embryos/group (see Figure S3B). MO reagent validation experiments are in Figure S2. Only MO-451 increased the N:C ratio, reflecting delayed erythrocyte maturation, in a dose-dependent manner. Data are mean plus or minus SE for n independent groups from 3 separate experiments. *P = .036; †P = .048 for the comparisons of MO-451-injected with control-injected and MOmiR-144-injected groups, respectively, 2-tailed t test. Figure S9 further demonstrates the reproducibility of these data by presenting them as scatterplots and providing additional fields of representative cells. (B) Knockdown of miR-144/451 does not affect neutrophil numbers and does not replicate the deficiency of mpx-expressing cells in mnr. Experiments were performed using WT or mnr embryos on the Tg(mpx:EGFP) background. Concentration of each MO injected was 1 mmol/L. Neutrophils were quantified by counting EGFP-positive cells/embryo at 48 hpf. *P < .0001 for comparison of mnr with all 4 other groups. (C-E) Overexpression of miR-451, but not miR-144, is sufficient to partially rescue the erythroid maturation block in mnr, as evident morphologically (D) and quantitatively (E) using the N:C area ratio. (C) A schema of the experimental design, which required genotyping embryos by nonhematologic phenotypic features at 48 hpf. Data are mean plus or minus SE for n independent experiments; ‡P < .0025 for line-by-line comparisons of WT to mnr, and §P = .035 and §§P = .003 for the indicated comparisons of miRNA-injected mnr with miR-C-injected mnr, 2-tailed t test. Scale bars = 5 μm. Figure S10 further demonstrates the reproducibility of these data by presenting them as scatterplots and providing additional fields of representative cells.

Functional studies of the role of miR-451 in erythroid maturation. (A) miR-451 deficiency, but not miR-144 deficiency, is sufficient to cause erythroid immaturity. MO miRNA antagonists or control MO was microinjected, tracing delivery by rhodamine (schematic diagram) and the N:C area ratio computed as an indicator of maturation (table). O-diansidine staining confirmed normal hemoglobinization in MO-injected embryos at 48 hpf (compare Figure 2C); embryos in panels are representative of at least 16 embryos/group (see Figure S3B). MO reagent validation experiments are in Figure S2. Only MO-451 increased the N:C ratio, reflecting delayed erythrocyte maturation, in a dose-dependent manner. Data are mean plus or minus SE for n independent groups from 3 separate experiments. *P = .036; †P = .048 for the comparisons of MO-451-injected with control-injected and MOmiR-144-injected groups, respectively, 2-tailed t test. Figure S9 further demonstrates the reproducibility of these data by presenting them as scatterplots and providing additional fields of representative cells. (B) Knockdown of miR-144/451 does not affect neutrophil numbers and does not replicate the deficiency of mpx-expressing cells in mnr. Experiments were performed using WT or mnr embryos on the Tg(mpx:EGFP) background. Concentration of each MO injected was 1 mmol/L. Neutrophils were quantified by counting EGFP-positive cells/embryo at 48 hpf. *P < .0001 for comparison of mnr with all 4 other groups. (C-E) Overexpression of miR-451, but not miR-144, is sufficient to partially rescue the erythroid maturation block in mnr, as evident morphologically (D) and quantitatively (E) using the N:C area ratio. (C) A schema of the experimental design, which required genotyping embryos by nonhematologic phenotypic features at 48 hpf. Data are mean plus or minus SE for n independent experiments; ‡P < .0025 for line-by-line comparisons of WT to mnr, and §P = .035 and §§P = .003 for the indicated comparisons of miRNA-injected mnr with miR-C-injected mnr, 2-tailed t test. Scale bars = 5 μm. Figure S10 further demonstrates the reproducibility of these data by presenting them as scatterplots and providing additional fields of representative cells.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal